Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Botulinum Toxin Type A (Botox) for the Treatment of Pain Associated With Cervical Dystonia and Refractory Cervicothoracic Myofascial Pain Syndrome

NCT00178945 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT00178945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00178945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Botulinum Toxin Type A (Botox) for the Treatment of Pain Associated With Cervical Dystonia and Refractory Cervicothoracic Myofascial Pain Syndrome
Lead sponsor
Vanderbilt University
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2004
Completion date
March 31, 2006
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical dystonia, refractory cervicothoracic myofascial pain syndrome (cmps)